|
1. Available at:
http://www.cdc.gov/tobacco/factsheets/Tobacco_Related_Mortality_factsheet.htm.
Accessed December 12, 2005.
2. Kang SY, Seeram NP, Nair MG, Bourquin LD.
Tart cherry anthocyanins inhibit tumor
development in Apc(Min) mice and reduce
proliferation of human colon cancer cells.
Cancer Lett. 2003 May 8;194(1):13-9.
3. Pratico D, Tillmann C, Zhang ZB, Li H,
FitzGerald GA. Acceleration of atherogenesis by
COX-1-dependent prostanoid formation in low
density lipoprotein receptor knockout mice. Proc
Natl Acad Sci USA. 2001 Mar
13;98(6):3358-63.
4. Tall JM, Seeram NP, Zhao C, et al. Tart
cherry anthocyanins suppress
inflammation-induced pain behavior in rat. Behav
Brain Res. 2004 Aug 12;153(1):181-8.
5. Wang H, Nair MG, Strasburg GM, et al.
Cyclooxygenase active bioflavonoids from Balaton
tart cherry and their structure activity
relationships. Phytomedicine. 2000
Mar;7(1):15-9.
6. Seeram NP, Momin RA, Nair MG, Bourquin LD.
Cyclooxygenase inhibitory and antioxidant
cyanidin glycosides in cherries and berries.
Phytomedicine. 2001 Sep;8(5):362-9.
7. Wang H, Nair MG, Strasburg GM, et al.
Antioxidant and antiinflammatory activities of
anthocyanins and their aglycon, cyanidin, from
tart cherries. J Nat Prod. 1999
Feb;62(2):294-6.
8. Kolayli S, Kucuk M, Duran C, Candan F,
Dincer B. Chemical and antioxidant properties of
Laurocerasus officinalis Roem. (cherry laurel)
fruit grown in the Black Sea region. J Agric
Food Chem. 2003 Dec 3;51(25):7489-94.
9. Wakabayashi H, Fukushima H, Yamada T, et
al. Inhibition of LPS-stimulated NO production
in mouse macrophage-like cells by Barbados
cherry, a fruit of Malpighia emarginata DC.
Anticancer Res. 2003 Jul;23(4):3237-41.
10. Nagamine I, Akiyama T, Kainuma M, et al.
Effect of acerola cherry extract on cell
proliferation and activation of ras signal
pathway at the promotion stage of lung
tumorigenesis in mice. J Nutr Sci Vitaminol
(Tokyo). 2002 Feb;48(1):69-72.
11. Jacob RA, Spinozzi GM, Simon VA, et al.
Consumption of cherries lowers plasma urate in
healthy women. J Nutr. 2003
Jun;133(6):1826-9.
12. Rimm EB, Katan MB, Ascherio A, Stampfer
MJ, Willett WC. Relation between intake of
flavonoids and risk for coronary heart disease
in male health professionals. Ann Intern Med.
1996 Sep 1;125(5):384-9.
13. Burkhardt S, Tan DX, Manchester LC,
Hardeland R, Reiter RJ. Detection and
quantification of the antioxidant melatonin in
Montmorency and Balaton tart cherries (Prunus
cerasus). J Agric Food Chem. 2001
Oct;49(10):4898-902.
14. Available at:
http://pubs.acs.org/pressrelease/jafc/release3.html.
Accessed December 15, 2005.
15. Available at:
http://www.wholehealthmd.com/print/view/1,1560,SU_10015,00.html.
Accessed December 15, 2005.
16. Available at:
http://www.wjla.com/news/stories/1005/272655.html.
Accessed December 15, 2005.
17. Available at:
http://www.fda.gov/bbs/topics/news/2005/new01246.html.
Accessed December 15, 2005.
18. Available at:
http://www.cfsan.fda.gov/~dms/chrylist.html.
Accessed December 15, 2005.
19. Available at: http://aspartametruth.com/
blaylock/interaction.html. Accessed December 15,
2005.
20. Available at:
http://www.inmotionmagazine.com/ geff4.html.
Accessed December 15, 2005.
21. Sasso FC, Carbonara O, Nasti R, et al.
Glucose metabolism and coronary heart disease in
patients with normal glucose tolerance. JAMA.
2004 Apr 21;291(15):1857-63.
22. Reiser S. Effect of dietary sugars on
metabolic risk factors associated with heart
disease. Nutr Health. 1985;3(4):203-16.
23. Pamplona R, Bellmunt MJ, Portero M, Prat
J. Mechanisms of glycation in atherogenesis. Med
Hypotheses. 1993 Mar;40(3):174-81.
24. Reyes FG, Valim MF, Vercesi AE. Effect of
organic synthetic food colours on mitochondrial
respiration. Food Addit Contam. 1996
Jan;13(1):5-11.
25. Jagerstad M, Skog K. Genotoxicity of
heat-processed foods. Mutat Res. 2005 Jul
1;574(1-2):156-72.
26. Sasaki YF, Kawaguchi S, Kamaya A, et al.
The comet assay with 8 mouse organs: results
with 39 currently used food additives. Mutat
Res. 2002 Aug 26;519(1-2): 103-19.
27. Tsuda S, Murakami M, Matsusaka N, et al.
DNA damage induced by red food dyes orally
administered to pregnant and male mice. Toxicol
Sci. 2001 May;61(1):92-9.
28. Ashida H, Hashimoto T, Tsuji S, Kanazawa
K, Danno G. Synergistic effects of food colors
on the toxicity of
3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole
(Trp-P-1) in primary cultured rat hepatocytes. J
Nutr Sci Vitaminol (Tokyo). 2000
Jun;46(3):130-6.
29. Tjaderhane L, Larmas M. A high sucrose
diet decreases the mechanical strength of bones
in growing rats. J Nutr. 1998
Oct;128(10):1807-10.
30. Veromann S, Sunter A, Tasa G, et al.
Dietary sugar and salt represent real risk
factors for cataract development.
Ophthalmologica. 2003 Jul;217(4):302-7.
31. Michaud DS, Liu S, Giovannucci E, et al.
Dietary sugar, glycemic load, and pancreatic
cancer risk in a prospective study. J Natl
Cancer Inst. 2002 Sep 4;94(17):1293-300.
32. Molteni R, Barnard RJ, Ying Z, Roberts
CK, Gomez-Pinilla F. A high-fat, refined sugar
diet reduces hippocampal brain-derived
neurotrophic factor, neuronal plasticity, and
learning. Neuroscience. 2002;112(4):803-14.
33. Blacklock NJ. Sucrose and idiopathic
renal stone. Nutr Health. 1987;5(1-2):9-17.
34. Moerman CJ, Bueno de Mesquita HB, Runia
S. Dietary sugar intake in the aetiology of
biliary tract cancer. Int J Epidemiol. 1993
Apr;22(2):207-14.
35. Kruis W, Forstmaier G, Scheurlen C,
Stellaard F. Effect of diets low and high in
refined sugars on gut transit, bile acid
metabolism, and bacterial fermentation. Gut.
1991 Apr;32(4):367-71.
36. Yudkin J, Eisa O. Dietary sucrose and
oestradiol concentration in young men. Ann Nutr
Metab. 1988;32(2):53-5.
37. De Stefani E, Deneo-Pellegrini H,
Mendilaharsu M, Ronco A, Carzoglio JC. Dietary
sugar and lung cancer: a case-control study in
Uruguay. Nutr Cancer. 1998;31(2):132-7.
38. Available at:
http://www.fda.gov/foi/warning_letters/g5531d.htm.
Accessed December 15, 2005.
39. Available at:
http://www.fda.gov/opacom/morechoices/mission.html.
Accessed December 15, 2005.
40. Available at:
http://www.finance.senate.gov/
sitepages/hearing111804.htm. Accessed December
15, 2005.
41. Available at: http://thomas.loc.gov/.
Accessed December 15, 2005.
42. Available at: http://www.house.gov/
paul/congrec/congrec2005/cr111005.htm. Accessed
December 15, 2005.
43. Available at:
http://www.fda.gov/opacom/laws/dshea.html.
Accessed December 15, 2005.
44. Available at: http://www.arthritis.org/
resources/arthritistoday/2002_archives/2002_09_10_OnCall.asp.
Accessed December 15, 2005.
45. Blando F, Gerardi C, Nicoletti I. Sour
cherry (Prunus cerasus L) anthocyanins as
ingredients for functional foods. J Biomed
Biotechnol. 2004;2004(5):253-8.
46. Martinez B. Novartis fights eczema drug’s
cancer warning. Wall Street Journal. April 8,
2005.
47. Bresalier RS, Sandler RS, Quan H, et al.
Cardiovascular events associated with rofecoxib
in a colorectal adenoma chemoprevention trial. N
Engl J Med. 2005 Mar 17;352(11):1092-102.
48. Topol EJ. Failing the public
healthrofecoxib, Merck, and the FDA. N Engl J
Med. 2004 Oct 21;351(17):1707-9.
49. Martinez B. Merck documents shed light on
Vioxx legal battles. Wall Street Journal.
February 7,
2005. |